Therapies

A new formulation of the Jetrea intravitreal injection has been listed on Pharmaceutical Benefits Scheme (PBS), replacing the current powder...

Controversial plans to dramatically reduce the rebate for intravitreal injections and also allow non-ophthalmologists to perform the procedure have divided...

New cases of incorrectly dispensed atropine formulations have prompted calls for eyecare professionals to make annotations to scripts in order...

Associate professor Simon Skalicky has been announced as Glaucoma Australia’s (GA) new president as the organisation aims to continue its...

Australian biotech company Opthea has reported a solid cash position to further advance clinical trials of its lead drug candidate...

A significant Australian study into the effectiveness of Allergan’s Ozurdex implant as a treatment for Diabetic Macular Oedema (DME) has...

Melbourne-based biotech company Opthea has demonstrated that combination therapy involving its lead drug candidate OPT-302 is superior to standalone Lucentis...

O=MEGA PREVIEW: Menicon Australia will be introducing the newest addition to the Miru family of contact lenses.The company will launch...

O=MEGA PREVIEW: Good Optical Services will display NuLids, a simple at-home dry eye treatment, as well as a new Sterileyes...

A new research project examining the proteins that circulate in the eye’s fluids has the potential to pave the way...